Rectal cancer staging: Focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging

Cancer Imaging

Volumn 13, Issue 2, 2013, Pages 277-297

  Dieguez, Adriana ^a  

^a Ciudad Autonoma de   (Argentina)

Author keywords

Group meeting; Magnetic resonance imaging; Prognosis; Rectal cancer; Staging; Treatment

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PREOPERATIVE TREATMENT; RECTUM CANCER; RECURRENCE FREE SURVIVAL; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME;

HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS;

EID: 84883085984     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2013.0028     Document Type: Review

References (155)

1. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355-364. doi:10.1002/bjs.4034. PMid:12594673. (Pubitemid 36324117)
2. Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol 2011; 21: 169-177. doi:10.1016/j.semradonc.2011.02.002. PMid:2164-5861.
3. Edge BE, Byrd D, Compton C, Fritz A, Greene F, Trotti A. AJCC cancer staging manual. 7th edition. Colon and rectum. New York: Springer-Verlag; 2010, p. 173-206.
4. Mercury Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779.
5. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systemic review and meta-analysis. Ann Surg Oncol 2012; 19: 2212-2223. doi:10.1245/s10434-011-2210- 5. PMid:22271205.
6. Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011; 29: 3753-3760. doi:10.1200/JCO.2011.34.9068. PMid:-21876084.
7. Shihab OC, Taylor F, Salerno G, et al. MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 2011; 18: 3278-3284. doi:10.1245/s10434-011-1776-2. PMid:2159-0-453.
8. Patel UB, Brown G, Rutten H, et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012; 19: 2842-2852. doi:10.1245/s10434-012-2309- 3. PMid:-22-526897.
9. Patel UB, Blomqvist LK, Taylor F, et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response -the MERCURY experience. AJR 2012; 199: 486-495. doi:10.2214/AJR.11.8210.
10. Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G. MRI for detection of extramural vascular invasion in rectal cancer. AJR 2008; 191: 1517-1522. doi:10.2214/AJR.08.1298. PMid:-18941094.
11. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imagingdetected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95: 229-236. doi:10.1002/bjs.5917. PMid:17932879.
12. Punt CJA, Buyse M, Kohne CH, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 2007; 99: 998-1003. doi:10.1093/jnci/djm024. PMid:-17596575. (Pubitemid 47232601)
13. Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol 2008; 47: 20-31. doi:10.1080/02841860701697720. PMid:-17957502.
14. Mercury Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the Mercury Study. Radiology 2007; 243: 132-139.
15. Cervantes A, Rosell-o S, Rodrguez-Braun E, et al. Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer. Ann Oncol 2008; 19(Suppl 7): 266-272.
16. Taylor F, Quirke P, Heald R, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II and III rectal cancer best managed by surgery alone. Ann Surg 2011; 253: 711-719. doi:10.1097/SLA.0b013e31820b8d52. PMid:21475011.
17. Hunter C, Garant A, Vuong T, et al. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment. Ann Surg Oncol 2012; 19: 1199-1205. doi:10.1245/s10434- 011-2036-1. PMid:-21913017.
18. Scholefield JH. Guidelines for the management of colorectal cancer. 3rd edition. London: Association of Coloproctology of Great Britain and Ireland; 2007.
19. Valentini V, Aristei C, Grimelius B, et al. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009; 92: 148-163. doi:10.1016/j.radonc.2009.06.027. PMid:19595467.
20. Aloia TA, Fahy BN. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer 2008; 7: 197-201. doi:10.3816/CCC. 2008.n.026. PMid:-18-621638. (Pubitemid 351758150)
21. Slupski M, Wlodarczyk Z, Jasinski M, Masztalerz M, Tujakowski J. Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg 2009; 52: 241-244.
22. Hillingso JG, Wille-Jorgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer-a systematic review. Colorectal Dis 2009; 11: 3-10. Erratum in: Colorectal Dis 2009; 11: 540.
23. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006; 93: 872-878. doi:10.1002/bjs.5346. PMid:16671066. (Pubitemid 44035261)
24. Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010; 210: 934-941. doi:10.1016/j.jamcollsurg.2010.-02.039. PMid:20510802.
25. Orlacchio A, Schillaci O, Fusco N, et al. Role of PET/CT in the detection of liver metastases from colorectal cancer. Radiol Med 2009; 114: 571-585. doi:10.1007/s11547-009-0393-7. PMid:-19444590.
26. Heriot AG, Hicks RJ, Drummond EG, et al. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 2004; 47: 451-458. doi:10.1007/s10350-003-0089-3. PMid:14978612. (Pubitemid 38436650)
27. Kong G, Jackson C, Koh DM, et al. The use of 18F-FDG PET/CT in colorectal liver metastases -comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 2008; 35: 1323-1329. doi:10.1007/s00259-008-0743-z. PMid:18347794.
28. Reinhardt MJ, Wiethoelter N, Matthies A, et al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging 2006; 33: 134-139. doi:10.1007/s00259-005-1901-1. PMid:16193313. (Pubitemid 43152879)
29. Expert Advisory Group on Cancer. A policy framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales 1995. Available at http://webarchive. nationalarchives.gov-.uk/20130107105354/http://www.dh.gov.uk/en/ Publicationsand-statistics/Publications/PublicationsPolicyAndGuidance/ DH-4071083.
30. Brown G. Specialist multidisciplinary team working in the treatment of cancer. BMJ 2012; 344: 2780. doi:10.1136/bmj.e2780.
31. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: results from a retrospective, comparative, interventional cohort study of 13722 women. BMJ 2012; 344: 2718. doi:10.1136/bmj.e2718.
32. Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 2006; 94: 351-357. doi:10.1038/sj.bjc.6602947. PMid:16465171. (Pubitemid 43237559)
33. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999; 25: 368-374. doi:10.1053/ejso.1999.0659. PMid:10419706. (Pubitemid 29364222)
34. Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002; 28: 126-134. doi:10.1053/ejso.2001.1231. PMid:11884047. (Pubitemid 35023653)
35. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899. doi:10.1001/archsurg. 133.8.894. PMid:9711965. (Pubitemid 28374285)
36. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646. doi:10.1056/NEJMoa010580. PMid:11547717.
37. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701. doi:10.1097/01.sla.-0000257358.56863.ce. PMid:17968156. (Pubitemid 350035641)
38. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-987.
39. Hawkes EA, Cunningham D, Tait D, Brown G, Chau I. Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm? Semin Radiat Oncol 2011; 21: 196-202. doi:10.1016/j.semradonc.2011.02.005. PMid:21645864.
40. Sauer R, Becker H, Hohenberger W, et al. German Rectal Cancer Study. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740. doi:10.1056/NEJMoa040694. PMid:15496622.
41. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223. doi:10.1002/bjs.5506. PMid:16983741. (Pubitemid 44547018)
42. Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 2012; 30: 3827-3833. doi:10.1200/JCO.2012-.-42. 9597. PMid:23008301.
43. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-29. doi:10.1093/jnci/80.1.21. PMid:3276900. (Pubitemid 18076565)
44. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-715. doi:10.1056/NEJM199103143241101. PMid:1997835.
45. Tepper JE, O-Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control-final report of Intergroup 0114. J Clin Oncol 2002; 20: 1744-1750. doi:10.1200/JCO.2002.07.132. PMid:11919230. (Pubitemid 34273262)
46. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993; 11: 1879-1887. PMid:8410113. (Pubitemid 23304611)
47. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004; 22: 1785-1796. doi:10.1200/JCO.2004.08.173. PMid:15067027. (Pubitemid 41095168)
48. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imagingdefined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-674. doi:10.1200/JCO.2005.04.4875. PMid:16446339. (Pubitemid 46630432)
49. Dewdney A, Cunningham D, Tabernero J, et al. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol 2012; 30: 1620-1627. doi:10.1200/JCO.2011.39.6036. PMid:22473163.
50. Glynne-Jones R, Kronfli M. Locally advanced rectal cancer: a comparison of management strategies. Drugs 2011; 71: 1153-1177. doi:10.2165/11591330- 000000000-00000. PMid:-21711061.
51. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer [see comments]. Lancet 1990; 335: 1055-1059. doi:10.1016/0140- 6736(90)92631-Q. PMid:1691810. (Pubitemid 20148648)
52. Willett CG. Technical advances in the treatment of patients with rectal cancer [editorial comment]. Int J Radiat Oncol Biol Phys 1999; 45: 1107-1108. doi:10.1016/S0360-3016(99)00329-6. PMid:10613301.
53. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001; 16: 298-304. PMid:11686527. (Pubitemid 32927002)
54. Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999; 42: 167-173. doi:10.1007/BF02237122. PMid:10211491. (Pubitemid 29085151)
55. Steel MC, Woods R, Mackay JM, Chen F. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 2002; 72: 483-487. doi:10.1046/j.1445-2197.2002.02457.x. PMid:12123507. (Pubitemid 34779377)
56. Miyoshi M, Ueno H, Hashiguchi Y, Mochizuki H, Talbot IC. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 2006; 243: 492-498. doi:10.1097/01.sla. 0000205627.05769.08. PMid:-16552200.
57. Taylor F, Mangat N, Swift LR, Brown G. Proforma-based reporting in rectal cancer. Cancer Imaging 2010; 10: 142-150. doi:10.1102/1470-7330.2010.9092.
58. Pedersen BG, Moran B, Brown G, Blomqvist L, Fenger-Grøn M, Laurberg S. Reproducibility of depth of extramural tumor spread and distance to circumferential resection margin at rectal MRI: enhancement of clinical guidelines for neoadjuvant therapy. AJR Am J Roentgenol 2011; 197: 1360-1366. doi:10.2214/AJR.11.6508. PMid:22109290.
59. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504. doi:10.1016/S0140-6736(00)04040-X. PMid:11229667. (Pubitemid 32173585)
60. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 1: 996-999. (Pubitemid 16005611)
61. Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845-853. doi:10.1016/j.ejso.-2005.05.002. PMid:15979269. (Pubitemid 41435253)
62. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-1102. doi:10.1016/S0016-5085(97)70119-7. PMid:9097991. (Pubitemid 27157519)
63. Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 1995; 48: 849-855. doi:10.1136/jcp.48.9.849. PMid:7490320.
64. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457. doi:10.1097/00000658- 200204000-00001. PMid:11923599. (Pubitemid 34258342)
65. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-334. doi:10.1046/j.0007-1323.2001.02024.x. PMid:11872058. (Pubitemid 34227032)
66. Hall NR, Finan T, Al-Jaberi T, Tsang CS, Brown SR, Dixon MF, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998; 41: 979-983. doi:10.1007/BF02237384. PMid:9715152. (Pubitemid 28369285)
67. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-711. doi:10.1016/S0140-6736(94)92206-3. PMid:7915774. (Pubitemid 24281421)
68. Taylor F, Swift R, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR 2008; 191: 1827-1835. doi:10.2214/AJR.08.1004. PMid:19020255.
69. Shihab O, Quirke P, Heald R, Moran B, Brown G. Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 2010; 97: 1431-1436. doi:10.1002/bjs.7116. PMid:20603854.
70. Sunderland D. The significance of vein invasion by cancer of the rectum and sigmoid: a microscopic study of 210 cases. Cancer 1949; 2: 429-437. doi:10.1002/1097-0142(194905)2:3-5429::AID-CNCR282002030743.0.CO;2-G. PMid:18131402.
71. Dukes C, Bussey HJ. Venous spread in rectal cancer. Proc R Soc Med 1941; 34: 571-573. PMid:19992363.
72. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ, Morson BC. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 1981; 5: 141-163. doi:10.1111/j.1365- 2559.1981.tb01774.x. PMid:7216178. (Pubitemid 11039331)
73. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ben Ari G. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988; 61: 1018-1023. doi:10.1002/1097-0142(19880301)61:551018::AID-CNCR2- 82061052743.0.CO;2-H. PMid:3338045. (Pubitemid 18058618)
74. Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Surg 1991; 162: 216-222. doi:10.1016/0002-9610(91)90073-M. PMid:1928581.
75. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983; 52: 1317-1329. doi:10.1002/1097-0142(19831001)52:751317:: AIDCNCR282052073143.0. CO;2-6. PMid:6192900. (Pubitemid 13006473)
76. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991; 34: 798-804. doi:10.1007/BF02051074. PMid:-1914747.
77. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980; 67: 439-442. doi:10.1002/bjs.1800670619. PMid:7388345. (Pubitemid 10059642)
78. Bokey EL, Chapuis PH, Dent OF, et al. Factors affecting survival after excision of the rectum for cancer: a multivariate analysis. Dis Colon Rectum 1997; 40: 3-10. doi:10.1007/BF02055674. PMid:9102257. (Pubitemid 27056391)
79. Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994; 25: 498-505. doi:10.1016/0046-8177(94)90122-8. PMid:8200644.
80. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg 1981; 14: 15-17. (Pubitemid 11170367)
81. Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 1984; 2: 733-736. PMid:6148482. (Pubitemid 14037045)
82. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482. PMid:2425199. (Pubitemid 16095660)
83. Bokey EL, Ojerskog B, Chapuis P, Dent O, Newland RC, Sinclair G. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg 1999; 86: 1164-1170. doi:10.1046/j.1365-2168.1999.01216.x. PMid:10504371. (Pubitemid 29427833)
84. Hermanek P, Merkel S, Fietkau R, Rodel C, Hohenberger W. Regional lymph node metastasis and locoregional recurrence of rectal cancer in the era of TNM surgery. Implications for treatment decisions. Int J Colorectal Dis 2010; 25: 359-368. doi:10.1007/s00384-009-0864-2. PMid:20012295.
85. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-332. doi:10.1002/path.1700350303.
86. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45: 200-206. doi:10.1007/s10350-004-6147-7. PMid:11852333. (Pubitemid 34141943)
87. Sitzler PJ, Seow-Choen F, Ho YH, Leong AP. Lymph node involvement and tumor depth in rectal cancers: An analysis of 805 patients. Dis Colon Rectum 1997; 40: 1472-1476. doi:10.1007/BF02070714. PMid:9407987. (Pubitemid 27528287)
88. Yamamoto S, Watanabe M, Hasegawa H, et al. The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology 2004; 51: 998-1000. PMid:15239233. (Pubitemid 38822457)
89. Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol 2006; 4: 1522-1527. doi:10.1016/j.cgh.2006.07.016. PMid:16979956. (Pubitemid 44880022)
90. Blumberg D, Paty PB, Guillem JG, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 1999; 42: 881-885. doi:10.1007/BF02237095. PMid:10411434. (Pubitemid 29328459)
91. Fang WL, Chang SC, Lin JK, et al. Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology 2005; 52: 1688-1691. PMid:16334758.
92. Baxter N, Garc-Aguilar J. Organ preservation for rectal cancer. J Clin Oncol 2007; 25: 1014-1020. doi:10.1200/JCO.2006.09.7840. PMid:17350952. (Pubitemid 350002869)
93. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high spatialresolution MR imaging with histopathologic comparison. Radiology 2003; 227: 371-377. doi:10.1148/radiol. 2272011747. PMid:12732695. (Pubitemid 36514749)
94. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. Highresolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004; 52: 78-83. doi:10.1016/j.ejrad.2003.12.005. PMid:15380850. (Pubitemid 39233657)
95. Koh DM, Brown G, Temple L, et al. Rectal cancer: mesorrectal lymph nodes at MR imaging with USPIO versus histopathologic findings -initial observations. Radiology 2004; 231: 91-99. doi:10.1148/radiol.2311030142. PMid:14976266. (Pubitemid 38379645)
96. Koh DM, George C, Temple L, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol 2010; 194: 505-513. doi:10.2214/AJR.08.1819.
97. Lambregts DM, Beets GL, Maas M, et al. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 2011; 253: 539-545. doi:10.1097/SLA.0b013e31820b01f1. PMid:21239980.
98. Lambregts DM, Heijnen LA, Maas M, et al. Gadofosvesetenhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging 2012: doi:10.1007/s00261-012-9957-4.
99. Suzuki K, Muto T, Sawada T. Prevention of local recurrence by extended lymphadenectomy for rectal cancer. Surg Today 1995; 25: 795-801. doi:10.1007/BF00311455. PMid:8555697.
100. Billingham RP. Extended lymphadenectomy for rectal cancer: cure vs quality of life. Int Surg 1994; 79: 11-22. PMid:8063549. (Pubitemid 24163837)
101. Moreira LF, Kenmotsu M, Gochi A, Tanaka N, Orita K. Lymphovascular and neural invasion in low-lying rectal carcinoma. Cancer Detect Prevent 1999; 23: 123-128. doi:10.1046/j.1525-1500.1999.09908.x. PMid:10101593. (Pubitemid 29139411)
102. Gunther K, Dworak O, Remke S, et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 2002; 103: 68-78. doi:10.1006/jsre.2001.6312. PMid:-11855920. (Pubitemid 34953394)
103. Hildebrandt U, Klein T, Feifel G, Schwarz HP, Koch B, Schmitt RM. Endosonography of pararectal lymph nodes. In vitro and in vivo evaluation. Dis Colon Rectum 1990; 33: 863-868. doi:10.1007/BF02051923. PMid:2209276. (Pubitemid 20350505)
104. Birbeck K, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457. doi:10.1097/00000658- 200204000-00001. PMid:-11923599. (Pubitemid 34258342)
105. Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorrectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004; 47: 1145-1149. doi:10.1007/s10350-004-0086-6. PMid:15164243. (Pubitemid 38857061)
106. Yano H, Saito Y, Kirihara Y, Takashima J. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma. Dis Colon Rectum 2006; 49: 1867-1877. doi:10.1007/s10350-006-0733-9. PMid:17080279. (Pubitemid 44853444)
107. Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998; 41: 55-61. doi:10.1007/BF02236896. PMid:9510311. (Pubitemid 28044876)
108. Singh AK, Myerson RJ, Birnbaum EH, et al. Outcome of patients with rectal adenocarcinoma and localized pelvic nonnodal metastatic foci. Dis Colon Rectum 2000; 43: 1217-1221. doi:10.1007/BF02237424. PMid:11005486.
109. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 2005; 242: 74-82. doi:10.1097/01.sla.00001-67926.60908.15. PMid:15973104. (Pubitemid 40917970)
110. Nagtegaal ID, van de Velde CJH, Marijnen CAM, van Krieken JHJM, Quirke P. Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-9264. doi:10.1200/JCO.2005.02.9231. PMid:-16361623.
111. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 2004; 47: 48-58. doi:10.1007/s10350-003-0012-y. PMid:14719151. (Pubitemid 38040245)
112. Shihab OC, Taylor F, Salerno G, et al. MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 2011; 18: 3278-3284. doi:10.1245/s10434-011-1776-2. PMid:21590453.
113. Salerno G, Chandler I, Wotherspoon A, Thomas K, Moran B, Brown G. Sites of surgical wasting in the abdominoperineal specimen. Br J Surg 2008; 95: 1147-1154. doi:10.1002/bjs.6231. PMid:18690619.
114. Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI staging of low rectal cancer. Eur Radiol 2009; 19: 643-650. doi:10.1007/s00330-008-1184-6. PMid:18810451.
115. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988; 3: 127-131. doi:10.1007/BF01645318. PMid:3045231.
116. Shihab OC, Heald R, Rullier E, Brown G, Holm T, Quirke P. Defining the surgical planes on MRI improves surgery for cancer of the low rectum. Lancet Oncol 2009; 10: 1207-1211. doi:10.1016/S1470-2045(09)70084-1. PMid:19959077.
117. Salerno G, Daniels I, Moran B, Heald R, Thomas K, Brown G. Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer. Dis Colon Rectum 2009; 52: 632-639. doi:10.1007/DCR. 0b013e3181a0a37e. PMid:-19404067.
118. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646. doi:10.1056/NEJMoa010580. PMid:11547717.
119. Dehni N, McFadden N, McNamara DA, Guiguet M, Tiret E, Parc R. Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum. Dis Colon Rectum 2003; 46: 867-874; discussion 874. doi:10.1007/s10350- 004-6675-1. PMid:12847358. (Pubitemid 36875480)
120. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum: an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 1997; 40: 747-751. doi:10.1007/BF02055425. PMid:9221846. (Pubitemid 27295041)
121. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo and radiation therapy. Radiology 2009; 253: 116-125. doi:10.1148/radiol.2532090027. PMid:19789256.
122. Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999; 211: 215-222. PMid:10189474. (Pubitemid 29161754)
123. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology. 2004; 232: 335-436. doi:10.1148/radiol.2322021326. PMid:15286305.
124. Brown G, Daniels IR, Richardson C, Revell P, Peppercorn D, Bourne M. Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. Br J Radiol 2005; 78: 245-251. doi:10.1259/bjr/33540239. PMid:15730990. (Pubitemid 40467647)
125. Brown G, Kirkham A, Williams GT, et al. High resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR 2004; 182: 431-439. doi:10.2214/ajr.182.2.1820431. PMid:14736677. (Pubitemid 38116588)
126. Blomqvist L, Rubio C, Holm T, Machado M, Hindmarsh T. Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol 1999; 72: 18-23. PMid:10341684. (Pubitemid 29067253)
127. Suzuki C, Torkzad MR, Tanaka S, et al. The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol 2008; 6: 89. doi:10.1186/1477-7819-6-89. PMid:18715510.
128. Bull AD, Biffin AH, Mella J, et al. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 1997; 50: 138-142. doi:10.1136/jcp.50.2.138. PMid:9155695. (Pubitemid 27093030)
129. Morris EJ, Maughan NJ, Forman D, Quirke P. Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology. Gut 2007; 56: 1419-1425. doi:10.1136/gut.2006.116830. PMid:17494107. (Pubitemid 47517838)
130. Georgiou PA, Tekkis PP, Brown G. Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options. Cancer Imaging 2011; 11: 103-111. doi:10.1102/1470-7330.2011.9025.
131. Rao AR, Kagan AR, Chan PM, Gilbert HA, Nussbaum H, Hintz BL. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer 1981; 48: 1492-1495. doi:10.1002/1097-0142-(19810915) 48:651492::AID-CNCR28204806364-3.0.CO;2-K. PMid:7272970. (Pubitemid 11042606)
132. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following curative surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg 1984; 71: 17-20. doi:10.1002/bjs.1800710105. PMid:6689963. (Pubitemid 14214646)
133. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976; 37: 2861-2865. doi:10.1002/1097-0142(197606)37:652861::AID-CNCR282037064343.0.CO;2-3. PMid:949706.
134. Sargent DJ, Wieand HS, Haller DG, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005; 23: 8664-8670. doi:10.1200/JCO.2005.01.6071. PMid:16260700. (Pubitemid 46211509)
135. Potter KC, Husband JE, Houghton SL, Thomas K, Brown G. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 2009; 52: 253-259. doi:10.1007/DCR.0b013e31819d11e6. PMid:19279420.
136. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003; 3: 26. doi:10.1186/1471-2407-3-26. PMid:14529575.
137. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002: CD002200. PMid:17253476.
138. Renehan AG, Egger M, Saunders MP, O-Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813. doi:10.1136/bmj.324.7341.813. PMid:11934773.
139. Brown G. Imaging for colorectal recurrence. Proceedings of the European Congress of Radiology, Vienna, 2010.
140. Desch CE, Benson AB, 3rd. Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23: 8512-8519.
141. Erratum in J Clin Oncol 2006; 24: 1224.
142. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-1189. PMid:10914907. (Pubitemid 30464000)
143. Asoglu O, Karanlik H, Muslumanoglu M, et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007; 33: 1199-1206. doi:10.1016/j.ejso. 2007.02.026. PMid:-17400423. (Pubitemid 350091348)
144. Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51: 284-291. doi:10.1007/s10350-007-9152-9. PMid:-18204879.
145. Dicle O, Obuz F, Cakmakci H. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 1999; 72: 1155-1159. PMid:10703471. (Pubitemid 30028927)
146. Zhang C, Chen Y, Xue H, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 2009; 124: 167-173. doi:10.1002/ijc.23926. PMid:18844237.
147. Moore HG, Akhurst T, Larson SM, Minsky BD, Mazumdar M, Guillem JG. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 2003; 197: 22-28. doi:10.1016/S1072-7515(03)00337-5. PMid:12831920. (Pubitemid 36759175)
148. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006; 238: 405-422. doi:10.1148/radiol.2382041977. PMid:16436809. (Pubitemid 43134354)
149. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 2004; 29: 663-668. doi:10.1007/s00261-003-0163-2. PMid:15162236. (Pubitemid 39331699)
150. Georgiou PA, Tekkis PP, Constantinides VA, et al. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer 2013; 49: 72-81. doi:10.1016/j.ejca.2012.06.025. PMid:23036847.
151. Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 2011; 21: 1250-1258. doi:10.1007/s00330-010-2052-8. PMid:-21240647.
152. Kim DJ, Kim JH, Lim JS, et al. Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 2010; 30: 503-516. doi:10.1148/rg.302095046. PMid:20228331.
153. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 2009; 253: 116-125. doi:10.1148/radiol.2532090027. PMid:19789256.
154. Barbaro B, Vitale R, Leccisotti L, et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 2010; 30: 699-716. doi:10.1148/rg.303095085. PMid:20462989.
155. Colosio A, Forne's P, Soyer P, Lewin M, Loock M, Hoeffel C. Local colorectal cancer recurrence: pelvic MRI evaluation. Abdom Imaging 2013; 38: 72-81. doi:10.1007/s00261-012-9891-5. PMid:22484342.